RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evoke Pharma Stock

Evoke Pharma P/E 2024

Evoke Pharma P/E

-0.57

Ticker

EVOK

ISIN

US30049G1040

WKN

A1W6DP

As of Dec 30, 2024, Evoke Pharma's P/E ratio was -0.57, a -18.57% change from the -0.7 P/E ratio recorded in the previous year.

The Evoke Pharma P/E history

Evoke Pharma Aktienanalyse

What does Evoke Pharma do?

Evoke Pharma Inc. is a pharmaceutical company that was founded in 2007 and is based in San Diego, California. It focuses on developing innovative drugs for gastrointestinal disorders. Evoke Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Evoke Pharma's P/E Ratio

The Price to Earnings (P/E) Ratio of Evoke Pharma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Evoke Pharma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Evoke Pharma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Evoke Pharma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Evoke Pharma stock

What is the price-to-earnings ratio of Evoke Pharma?

The price-earnings ratio of Evoke Pharma is currently -0.57.

How has the price-earnings ratio of Evoke Pharma changed compared to last year?

The price-to-earnings ratio of Evoke Pharma has increased by -18.57% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Evoke Pharma high compared to other companies?

Yes, the price-to-earnings ratio of Evoke Pharma is high compared to other companies.

How does an increase in the price-earnings ratio of Evoke Pharma affect the company?

An increase in the price-earnings ratio of Evoke Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Evoke Pharma affect the company?

A decrease in the price-earnings ratio of Evoke Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Evoke Pharma?

Some factors that influence the price-earnings ratio of Evoke Pharma are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Evoke Pharma pay?

Over the past 12 months, Evoke Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evoke Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Evoke Pharma?

The current dividend yield of Evoke Pharma is .

When does Evoke Pharma pay dividends?

Evoke Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evoke Pharma?

Evoke Pharma paid dividends every year for the past 0 years.

What is the dividend of Evoke Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evoke Pharma located?

Evoke Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evoke Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evoke Pharma from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did Evoke Pharma pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of Evoke Pharma in the year 2023?

In the year 2023, Evoke Pharma distributed 0 USD as dividends.

In which currency does Evoke Pharma pay out the dividend?

The dividends of Evoke Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Evoke Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Evoke Pharma

Our stock analysis for Evoke Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evoke Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.